Skoglund E - Search Results

1

In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways.

Skoglund E, Abodakpi H, Rios R, Diaz L, De La Cadena E, Dinh AQ, Ardila J, Miller WR, Munita JM, Arias CA, Tam VH, Tran TT. Skoglund E, et al. Case Rep Infect Dis. 2018 Dec 23;2018:9095203. doi: 10.1155/2018/9095203. eCollection 2018. Case Rep Infect Dis. 2018. PMID: 30675406 Free PMC article.

2

Corrigendum to "In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways".

Skoglund E, Abodakpi H, Rios R, Diaz L, De La Cadena E, Dinh AQ, Ardila J, Miller WR, Munita JM, Arias CA, Tam VH, Tran TT. Skoglund E, et al. Case Rep Infect Dis. 2019 Sep 2;2019:8314349. doi: 10.1155/2019/8314349. eCollection 2019. Case Rep Infect Dis. 2019. PMID: 31565449 Free PMC article.

3

Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates.

Skoglund E, Ledesma KR, Lasco TM, Tam VH. Skoglund E, et al. J Glob Antimicrob Resist. 2017 Dec;11:154-155. doi: 10.1016/j.jgar.2017.10.016. Epub 2017 Oct 31. J Glob Antimicrob Resist. 2017. PMID: 29101084 No abstract available.

4

Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.

McLaughlin MM, Miglis C, Skoglund E, Wagner J, Advincula MR, Scheetz MH. McLaughlin MM, et al. Among authors: skoglund e. J Glob Antimicrob Resist. 2018 Jun;13:261-263. doi: 10.1016/j.jgar.2018.02.003. Epub 2018 Feb 9. J Glob Antimicrob Resist. 2018. PMID: 29432939

5

Economic health care costs of blood culture contamination: A systematic review.

Dempsey C, Skoglund E, Muldrew KL, Garey KW. Dempsey C, et al. Among authors: skoglund e. Am J Infect Control. 2019 Aug;47(8):963-967. doi: 10.1016/j.ajic.2018.12.020. Epub 2019 Feb 20. Am J Infect Control. 2019. PMID: 30795840

6

Significant Publications on Infectious Diseases Pharmacotherapy in 2016.

Fong G, Skoglund EW, Phe K, Guastadisegni J, Shea KM, McDaneld PM, Perez KK, Sofjan AK. Fong G, et al. J Pharm Pract. 2018 Oct;31(5):469-480. doi: 10.1177/0897190017727212. Epub 2017 Aug 29. J Pharm Pract. 2018. PMID: 28847232 Review.

7

Microbiologic clearance following transition from standard infusion piperacillin-tazobactam to extended-infusion for persistent Gram-negative bacteremia and possible endocarditis: A case report and review of the literature.

D'Agostino C, Rhodes NJ, Skoglund E, Roberts JA, Scheetz MH. D'Agostino C, et al. Among authors: skoglund e. J Infect Chemother. 2015 Oct;21(10):742-6. doi: 10.1016/j.jiac.2015.05.010. Epub 2015 Jun 9. J Infect Chemother. 2015. PMID: 26143049

8

Drug shortages and patient safety: an overview of essential information for the infusion nurse.

McLaughlin MM, Skoglund EW. McLaughlin MM, et al. J Infus Nurs. 2015 May-Jun;38(3):205-8. doi: 10.1097/NAN.0000000000000101. J Infus Nurs. 2015. PMID: 25871867

9

Peramivir: an intravenous neuraminidase inhibitor.

McLaughlin MM, Skoglund EW, Ison MG. McLaughlin MM, et al. Expert Opin Pharmacother. 2015;16(12):1889-900. doi: 10.1517/14656566.2015.1066336. Epub 2015 Jul 8. Expert Opin Pharmacother. 2015. PMID: 26153242 Review.

10

Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages.

McLaughlin MM, Skoglund E, Pentoney Z, Scheetz MH. McLaughlin MM, et al. Among authors: skoglund e. Infect Dis Ther. 2014 Dec;3(2):349-55. doi: 10.1007/s40121-014-0040-z. Epub 2014 Sep 19. Infect Dis Ther. 2014. PMID: 25234281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters